DaVita HealthCare Partners Inc (DVA)
Working capital turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 12,140,150 | 11,911,290 | 11,738,650 | 11,665,040 | 11,609,900 | 11,636,980 | 11,626,610 | 11,616,360 | 11,618,800 | 11,580,150 | 11,565,900 | 11,529,370 | 11,550,610 | 11,543,870 | 11,523,880 | 11,486,600 | 11,388,470 | 11,311,010 | 11,254,260 | 11,298,510 |
| Total current assets | US$ in thousands | 3,137,910 | 3,135,360 | 3,001,970 | 3,039,740 | 3,155,290 | 3,202,440 | 3,264,110 | 3,128,710 | 3,167,720 | 3,839,540 | 3,978,590 | 3,866,680 | 3,148,720 | 3,429,680 | 5,779,830 | 4,023,940 | 3,690,170 | 3,998,720 | 6,390,630 | 9,225,080 |
| Total current liabilities | US$ in thousands | 2,642,210 | 2,537,930 | 2,403,420 | 2,565,090 | 2,619,750 | 2,537,410 | 2,310,750 | 2,420,450 | 2,398,530 | 2,363,050 | 2,386,040 | 2,314,720 | 2,476,140 | 2,499,240 | 4,274,560 | 2,220,750 | 2,372,100 | 2,206,640 | 5,706,940 | 8,230,880 |
| Working capital turnover | 24.49 | 19.94 | 19.61 | 24.58 | 21.68 | 17.50 | 12.20 | 16.40 | 15.11 | 7.84 | 7.26 | 7.43 | 17.17 | 12.41 | 7.66 | 6.37 | 8.64 | 6.31 | 16.46 | 11.36 |
December 31, 2023 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $12,140,150K ÷ ($3,137,910K – $2,642,210K)
= 24.49
The working capital turnover of DaVita Inc has shown fluctuations over the past eight quarters. The ratio peaked in Q4 2023 at 24.49, indicating that DaVita Inc generated $24.49 in revenue for every dollar of working capital invested during that period. This increase from the previous quarter suggests an improvement in the efficiency of using working capital to generate revenue.
However, the working capital turnover in Q3 and Q2 2023, as well as in Q4 and Q3 2022, was lower compared to Q4 2023. This indicates that DaVita Inc was less efficient in utilizing its working capital to generate revenue during those quarters.
Overall, the trend in working capital turnover suggests some variability in how efficiently DaVita Inc is utilizing its working capital to generate revenue, with Q4 2023 standing out as a particularly strong period in this regard. Further analysis of the company's operations and financial performance may be needed to understand the factors influencing these fluctuations in working capital turnover.
Peer comparison
Dec 31, 2023